
Results
3
3 companies
MedinCell
Market Cap: €901.2m
A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€25.10
7D
-6.6%
1Y
57.9%
DBV Technologies
Market Cap: €735.6m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.49
7D
-11.6%
1Y
52.1%
ABIVAX Société Anonyme
Market Cap: €10.2b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
ABVX
€118.10
7D
-1.7%
1Y
1,210.8%